Should AML Patients be Tested for FLT3? @UCSFCancer

Should AML Patients be Tested for FLT3? @UCSFCancer

obr

1 month
0 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Catherine Smith, MD, Assistant Professor, Division of Hematology/Oncology, Department of Medicine, @UCSFCancer on whether all acute myeloid leukemia (AML) patients should be tested for FLT3.
Up Next Autoplay